US 12263139
Use of cannabidiol in the treatment of tuberous sclerosis complex
granted A61KA61K31/352A61K31/436
Quick answer
US patent 12263139 (Use of cannabidiol in the treatment of tuberous sclerosis complex) held by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/352, A61K31/436, A61K31/658, A61K45/06